Correlation Between Pmv Pharmaceuticals and Hillevax

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Hillevax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Hillevax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Hillevax, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Hillevax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Hillevax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Hillevax.

Diversification Opportunities for Pmv Pharmaceuticals and Hillevax

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pmv and Hillevax is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Hillevax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hillevax and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Hillevax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hillevax has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Hillevax go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and Hillevax

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Hillevax. But the stock apears to be less risky and, when comparing its historical volatility, Pmv Pharmaceuticals is 1.01 times less risky than Hillevax. The stock trades about -0.04 of its potential returns per unit of risk. The Hillevax is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  1,750  in Hillevax on August 25, 2024 and sell it today you would lose (1,564) from holding Hillevax or give up 89.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.8%
ValuesDaily Returns

Pmv Pharmaceuticals  vs.  Hillevax

 Performance 
       Timeline  
Pmv Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Pmv Pharmaceuticals is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.
Hillevax 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hillevax has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Hillevax is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pmv Pharmaceuticals and Hillevax Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pmv Pharmaceuticals and Hillevax

The main advantage of trading using opposite Pmv Pharmaceuticals and Hillevax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Hillevax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hillevax will offset losses from the drop in Hillevax's long position.
The idea behind Pmv Pharmaceuticals and Hillevax pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance